Form 4 for MGNX MACROGENICS INC
Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-12 · accession 0001588365-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-17 | 2026-02-15 | MGNX | Bonvini Ezio | SVP, CSO, Research | M - OptEx | — | +16.7K | 152.2K | +12% | — |
| D | 2026-02-17 | 2026-02-15 | MGNX | Bonvini Ezio | SVP, CSO, Research | F - Tax | $1.71 | -6,433 | 145.8K | -4% | -$11.0K |
| D | 2026-02-17 | 2026-02-15 | MGNX | Bonvini Ezio | SVP, CSO, Research | M - OptEx | $0.00 | -16.7K | 0 | -100% | $0 |
| DM | 2026-02-17 | 2026-02-12 | MGNX | Bonvini Ezio | SVP, CSO, Research | A - Grant | $0.00 | +218.8K | 31.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-15 | M | A | 16,665 | — | 152,232 | D | — | — | (F1) On February 15, 2023, the reporting person was granted 50,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2026-02-15 | F | D | 6,433 | $1.71 | 145,799 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2026-02-15 | M | D | 16,665 | $0.00 | 0 | D | — · — to — | 16,665 Common Stock | (F1) On February 15, 2023, the reporting person was granted 50,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2026-02-12 | A | A | 187,500 | $0.00 | 187,500 | D | $1.71 · — to 2036-02-12 | 187,500 Common Stock | (F3) 12.5% of the shares underlying the grant became exercisable one year after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter. |
| 5 | Derivative | Restricted Stock Unit | 2026-02-12 | A | A | 31,250 | $0.00 | 31,250 | D | — · — to — | 31,250 Common Stock | (F2) Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. |